Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement


Autoria(s): Bullock, R; Passmore, P; Wilkinson, D; Howard, R; Jones, R
Data(s)

2000

Identificador

http://pure.qub.ac.uk/portal/en/publications/effectiveness-of-rivastigmine-in-alzheimers-disease-participation-in-trials-should-be-based-on-clinical-uncertainty-not-enforcement(246b303a-cc84-467d-8587-67cd95d5d98d).html

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Bullock , R , Passmore , P , Wilkinson , D , Howard , R & Jones , R 2000 , ' Effectiveness of rivastigmine in Alzheimer's disease. Participation in trials should be based on clinical uncertainty, not enforcement ' BMJ (Clinical research ed.) , vol 320 , no. 7233 , pp. 511-2 .

Tipo

article